Tubular carcinoma, treatable and slow-growing, has a good prognosis and often needs less aggressive treatment.

- sNDA filing for revumenib in R/R mNPM1 AML expected in 2Q25 based on positive pivotal data from AUGMENT-101 trial - NEW YORK, March 03, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX) ...

1, 2 Long-term outcome data shows variable rates of disease progression throughout the world. Attempts have been made to identify clinical, laboratory and morphologic features in renal biopsies, which ...

[2025], Figure 1. Deutsch et al. [2025] use a machine learning-derived catalog of hollow degradation states, based on morphologic characteristics and reflectance signatures, to study the spatial ...

Introduction: In this study, we explored the effectiveness and safety of the immune checkpoint inhibitor camrelizumab in combination with chemotherapy for the treatment of cervical cancer by ...

The trapped or “parasitic twin” has some morphologic features of a normal foetus such as an umbilical cord-like structure, a bag of membranes surrounding it, and blood vessel connections to ...